5 tips to get your health tech product to market quickly

You will also find some examples of how our independent advisory service for life sciences companies, NICE advicecan help you. NICE Advice operates separately from our guidance producing programs and offers competitively priced, expert support to companies willing to invest in their market entry strategy.

1. Understand and align with NHS priorities and challenges

Consider how your product addresses specific NHS priorities and challenges, such as reducing waiting times, improving patient outcomes in key clinical areas or increasing system efficiency. Align your value proposition accordingly to increase your product’s appeal to NHS decision makers and accelerate adoption.

Topics to be prioritized in guideline development are described in our outlook. If your topic is not a priority, NICE Advice is ready to support you in preparing for your engagement with NHS payers or commissioners. We encourage you please contact us.

2. Register your product with the NHS Innovation Service

This free online platform is your gateway to offering innovative healthcare solutions to NHS patients. It provides co-ordinated support from leading organisations, including NICE, and provides useful information such as details about financing options and competitions. Keeping track of your technology in a centralized manner allows the NHS Innovation Service ensures your product is on the radar of key national organizations such as NICE, NHS Supply Chain and NHS England.

3. Engage in discussions with the healthcare system early

Early engagement with relevant stakeholders, such as local NHS organisations, regional healthcare innovation networksor national support services such as NICE Advice, are crucial. Such collaborations can help you secure buy-in and gain confidence in your approach.

You will find early involvement with NICE Advice particularly valuable. We can help you get your proof plans and market entry strategies right the first time, saving you time and money. Do you want to avoid costly missteps and revisions later in the development process? To consider our support as a prudent risk-mitigating investment for your future success.

4. Identify your route to market

Understanding your most effective route to the NHS is essential to avoiding delays. It is critical to ensure that your health technology product reaches the patients it is designed for.

NICE Advice offers a 1-hour surgery with an overview of relevant NHS access routes and a 2 to 3 hour system engagement meeting for more complex issues. These services can help you navigate your route to market through conversations with experts and stakeholders.

5. Identify blind spots on evidence

As part of the NHS England’s health technology assessment body, we help set the evidence standards for national market access. Without a robust evidence base and an impactful value proposition, you risk delays in market entry.

NICE Advice’s evidence gap analysis service (META tool) can help you identify weaknesses, avoid costly mistakes and prepare effectively for entering the NHS market. This service includes a meeting with a NICE expert and a report highlighting key gaps and recommended actions.

For products recommended for early use in the NHS through our Early Value Assessment Programwe provide support in developing targeted plans for generating evidence and facilitating collaborations with key stakeholders. The aim is to support health technology developers to produce the evidence needed to make a clear recommendation on future routine NHS use.

Taking the next step

Are you ready to take the next step on your market access journey? Contact the friendly and helpful team at NICE Advice. Completing our application form only takes a few minutes. Simply provide a brief overview of your product and the type of support you are looking for and we will contact you.

Stay informed

Want to stay informed about the latest developments from NICE? Subscribe to our newsletterNICE News for Life Sciences, and you will receive the latest information directly in your inbox.